Carregant...
Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis
Currently, there is no effective vaccine to halt HIV transmission. However, pre-exposure prophylaxis (PrEP) with the drug combination Truvada can substantially decrease HIV transmission in individuals at risk. Despite its benefits, Truvada-based PrEP is expensive and needs to be taken once-daily, wh...
Guardat en:
| Publicat a: | PLoS Comput Biol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6370240/ https://ncbi.nlm.nih.gov/pubmed/30699105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pcbi.1006740 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|